Skip to content

Analysis of Correlation between Mass of Muscle/Fat and Tolerability of Chemotherapy in Patients with Advanced Cancer

Analysis of Correlation between Mass of Muscle/Fat and Tolerability of Chemotherapy in Patients with Advanced Cancer - Correlation between Mass of Muscle/Fat and Tolerability of Chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000037186
Enrollment
100
Registered
2019-06-26
Start date
2019-06-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Advanced Cancer

Interventions

None listed

Sponsors

Chiba University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Advanced cancer (2)Chemotherapy

Exclusion criteria

Exclusion criteria: Patients who decline mass of muscle/fat

Design outcomes

Primary

MeasureTime frame
Correlation between (1)Mass of muscle/fat and their change and (2)severe AEs, PS, change of regimen,dose reduction, BSC, prognosis.

Countries

Japan

Contacts

Public ContactMakoto Arai

Chiba University Clinical Oncology

araim-cib@umin.ac.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026